Ashley L. Ward
MacroGenics
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ashley L. Ward as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:50 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04634825 · Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck CancerMacroGenics · terminated · Head and Neck Cancer, Head and Neck Neoplasms, Head and Neck Squamous Cell Carcinoma · study director
- Ph1/Ph2NCT02152956 · Flotetuzumab in Primary Induction Failure (PIF) or Early Relapse (ER) Acute Myeloid Leukemia (AML)MacroGenics · terminated · AML · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:50 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:50 UTC. The ranking covers the 200 most relevant of 3 PubMed records, and a shared surname and initials can bring in a namesake. All 3 on PubMed
- Eating in the absence of hunger in children with mild sleep loss: a randomized crossover trial with learning effects.Am J Clin Nutr · 202116 citationsRCR 1.6
- The effect of modest changes in sleep on dietary intake and eating behavior in children: secondary outcomes of a randomized crossover trial.Am J Clin Nutr · 202314 citationsRCR 2.4
- 10 citationsRCR 0.7